Advertisement
Canada markets closed
  • S&P/TSX

    22,465.37
    +165.57 (+0.74%)
     
  • S&P 500

    5,308.13
    +4.86 (+0.09%)
     
  • DOW

    39,806.77
    -196.82 (-0.49%)
     
  • CAD/USD

    0.7341
    -0.0007 (-0.10%)
     
  • CRUDE OIL

    79.65
    -0.15 (-0.19%)
     
  • Bitcoin CAD

    94,984.18
    +4,503.95 (+4.98%)
     
  • CMC Crypto 200

    1,489.60
    +135.19 (+9.98%)
     
  • GOLD FUTURES

    2,434.10
    -4.40 (-0.18%)
     
  • RUSSELL 2000

    2,102.50
    +6.78 (+0.32%)
     
  • 10-Yr Bond

    4.4370
    +0.0170 (+0.38%)
     
  • NASDAQ

    16,794.88
    +108.91 (+0.65%)
     
  • VOLATILITY

    12.15
    +0.16 (+1.33%)
     
  • FTSE

    8,424.20
    +3.94 (+0.05%)
     
  • NIKKEI 225

    39,069.68
    +282.30 (+0.73%)
     
  • CAD/EUR

    0.6757
    +0.0002 (+0.03%)
     

AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales

AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales

Fears that Humira biosimilars will erode AbbVie's topline are overblown, an analyst said Monday. He has an outperform rating on AbbVie stock.